Galapagos

GLPG NASDAQ
183.40
+9.39
+5.40%
休市 16:00 07/19 EDT
开盘
185.13
昨收
174.01
最高
186.74
最低
180.74
成交量
72.36万
成交均量(3M)
15.05万
52周最高
186.74
52周最低
85.00
换手率
1.32%
市值
100.16亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Galapagos GLPG股票价格,Galapagos股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In addition, the Company’s mission is to develop a number of medicines based on the discovery of novel targets. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. Galapagos aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease.
展开 >

最近浏览

名称
价格
涨跌幅